Description

Specifications

• Form: White lyophilized powder, dual-peptide blend
• Standard vial size: 10mg total (5mg BPC-157 / 5mg TB-500)
• Purity: ≥99% each peptide (HPLC & Mass Spec verified)
• Storage: Store lyophilized powder at -20°C; refrigerate at 2–8°C once reconstituted

Overview

This blend pre-combines two of the most studied tissue-repair peptides, BPC-157 and TB-500, in a single vial for researchers investigating their combined effects on wound healing and connective-tissue repair.

Mechanism & Research Findings

BPC-157’s angiogenic, NO-pathway signaling and TB-500’s actin-regulated cell-migration effects are believed to act on complementary stages of the tissue-repair cascade. Combination studies in animal injury models have reported additive or synergistic improvements in healing rate compared to either peptide administered alone, making this a frequently referenced pairing in musculoskeletal and soft-tissue repair research.

Research Applications

• Combined angiogenesis + cytoskeletal repair pathway studies
• Musculoskeletal and connective-tissue injury models
• Synergy research vs. single-peptide protocols

For laboratory research use only. Not for human consumption, diagnostic, or therapeutic use.